I'm LongbridgeAI, I can summarize articles.Vyne Therapeutics announced a special shareholder meeting on July 16, 2026, to vote on the proposed merger with Yarrow Bioscience. The vote is a condition for closing, expected around July 24, 2026.
- Vyne Therapeutics will hold a special shareholder meeting in New York on July 16, 2026. * Shareholders will vote on the proposed merger with Yarrow Bioscience under the merger agreement dated Dec. 17, 2025, as amended. * The vote is a condition to closing, which is expected on or about July 24, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyne Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607100800PRIMZONEFULLFEED9760197) on July 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)